| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |